ETANERCEPT

etanercept 50 mg/mL injection, 4 x 1 mL pen devices

ETANERCEPT (1964J)

etanercept 50 mg/mL injection, 4 x 1 mL pen devices
1964J
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 1 treatment (Whole body) - biological medicine-naive patient

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 2 treatment (Whole body) - Change of treatment

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 3 treatment (Whole body, or, face/hand/foot) - Recommencement of treatment after a break in biological medicine of more than 5 years

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Balance of supply - Initial 1, 2, 3 or 4 treatment (Whole body, or, face/hand/foot)

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 4 - Re-treatment (Whole body)

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 1 treatment (Face, hand, foot) - biological medicine-naive patient

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 2 treatment (Face, hand, foot) - Change of treatment

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Initial 4 - Re-treatment (face, hand, foot)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 3 DPMQ: $846.42 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Enbrel
Erelzi
Nepexto